Patisiran Alternatives Compared
Patisiran | Eplontersen | Vutrisiran |
|
---|
Patisiran | Eplontersen | Vutrisiran |
|
---|---|---|---|
Prescription only
Prescribed for Transthyretin-Related Amyloidosis, Hereditary Amyloidosis. patisiran may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Transthyretin-Related Amyloidosis, Hereditary Amyloidosis. eplontersen may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hereditary Amyloidosis, Transthyretin-Related Amyloidosis. vutrisiran may also be used for purposes not listed in this medication guide. |
|
More about Patisiran | More about Eplontersen | More about Vutrisiran | |
Ratings & Reviews | |||
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
|
Drug Class | |||
Side Effects | |||
See also: patisiran side effects in more detail. |
See also: eplontersen side effects in more detail. |
See also: vutrisiran side effects in more detail. |
|
Generic Availability | |||
N/A |
N/A |
N/A |
|
Pricing and Coupons * Prices are without insurance | |||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Form(s) Available | |||
N/A |
N/A |
N/A |
|
Brand Names | |||
Onpattro | Wainua | Amvuttra | |
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||
76.8 hours |
504 hours |
5.2 hours |
|
CSA Schedule ** View glossary of terms | |||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category | |||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
Drug Interactions | |||
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
Alcohol/Food/Lifestyle Interactions | |||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
Disease Interactions | |||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||
First Approval Date | |||
August 10, 2018 |
N/A |
June 13, 2022 |
|
WADA Class View World Anti-Doping Agency classifications. | |||
N/A |
N/A |
N/A |
|
More Information | |||
Patient resources | |||
Professional Resources | |||
Related Treatment Guide | |||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.